LPL Financial
AIMT

LPL Financial’s Aimmune Therapeutics AIMT Stock Holding History

LPL Financial’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,728
Closed -$301K – 3925
2020
Q3 		$301K Buy
+8,728
New +$186K ﹤0.01% 2910
2020
Q1 		– Sell
-7,944
Closed -$266K – 3491
2019
Q4 		$266K Buy
+7,944
New +$222K ﹤0.01% 2873

LPL Financial's AIMT Position: Q4 2020 in Review

LPL Financial sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 8,728 shares — an estimated $301K sold.

LPL Financial first reported a position in AIMT in Q4 2019 and held it in 2 quarters. The position peaked at $301K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • LPL Financial reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • LPL Financial sold 8,728 Aimmune Therapeutics shares in Q4 2020, an estimated $301K.
  • LPL Financial first reported a position in Aimmune Therapeutics in Q4 2019 and held it in 2 quarters.
  • LPL Financial's Aimmune Therapeutics position peaked at $301K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on LPL Financial's 13F filing for Q4 2020, filed 12 Feb 2021.